lettermovir

The drug is used for the prevention of reactivation and disease caused by cytomegalovirus (CMV) in adult patients who have undergone hematopoietic stem cell transplantation or kidney transplantation.

Form: tablets, film-coated

ATC: J05AX18

Manufacturer: Organon Heist bv (primary and secondary packaging, batch release authorization)

The drug is used for the prevention of cytomegalovirus (CMV) infection reactivation and CMV disease in adult patients who have received an allogeneic hematopoietic stem cell transplant or a kidney transplant from a CMV-seropositive donor.

Form: concentrate for infusion solution

ATC: J05AX18

Manufacturer: MSD International GmbH/MSD Ireland (Carlow), Ireland (manufacturing, primary packaging and analytical testing, stability testing)